Machine learning prediction for early-stage melanoma outcomes: recurrence-free survival, disease-specific survival, and overall survival
Wan, G.; Rashdan, H.; Burke, O. M.; Khattab, S.; Nguyen, N.; Leung, B. W.; Beagles, E.; Chang, C. T.; Yu, K.-H.; DeSimone, M. S.; Semenov, Y. Y.
Show abstract
This study compared machine-learning models for predicting recurrence-free survival (RFS), disease-specific survival (DSS), and overall survival (OS) using clinicopathologic data from 1,621 stage I/II primary cutaneous melanoma patients. Our time-to-event models achieved concordance indices of 0.829 for RFS, 0.812 for DSS, and 0.778 for OS. Tumor thickness and mitotic rate were the most important predictors for RFS. Charlson comorbidity score and insurance type were critical for DSS and OS.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Baseline tumor-infiltrating lymphocyte patterns and response to immune checkpoint inhibition in metastatic cutaneous melanoma 96%
- Development of an artificial intelligence-generated, explainable treatment recommendation system for urothelial carcinoma and renal cell carcinoma to support multidisciplinary cancer conferences 89%
- Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: a multicentre study. 88%
Similar papers in this journal
Similar papers in this journal
- Machine learning predicts rapid relapse of triple negative breast cancer 90%
- Molecular subtyping improves prognostication of Stage 2 colorectal cancer 90%
- ALLIANCE A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer 90%
Similar papers in this journal
- Explainable, federated deep learning model predicts disease progression risk of cutaneous squamous cell carcinoma 92%
- Survival-Inferred Fragility of Statistical Significance in Phase III Oncology Trials 89%
- Development and validation of a gene expression score to account for tumour purity and improve prognostication in breast cancer 89%
Similar papers in this journal
- Explainable machine learning identifies features and thresholds predictive of immunotherapy response 94%
- Matched three-dimensional organoids and two-dimensional cell lines of melanoma brain metastases mirror response to targeted molecular therapy 91%
- Comparison of Radiomic Feature Aggregation Methods for Patients with Multiple Tumors 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.